Literature DB >> 1473429

Inhibition and stimulation of prolactin release. Delayed response in duodenal ulcer patients.

I Rotkvić1, D Hrabar, H Krpan, M Banić, T Brkić, M Duvnjak, V Zjacić, P Sikirić.   

Abstract

Prolactin inhibitory tests (bromocriptine in a single dose 2.5 mg orally) as well as stimulatory tests (metoclopramide in a single dose of 10 mg intravenously) were performed in 33 patients with endoscopically proven duodenal ulcer and in 32 healthy volunteers. Delayed response in inhibition of prolactin release as well as in stimulation of prolactin release was observed in duodenal ulcer patients compared to healthy volunteers (P < 0.01). The results implicate the role of the dopamine-prolactin axis in the pathogenesis of duodenal ulcer disease.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1473429     DOI： 10.1007/bf01308073

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


  11 in total

1.  Dopamine agonists prevent duodenal ulcer relapse. A comparative study with famotidine and cimetidine.

Authors:  P Sikiric; I Rotkvic; S Mise; M Petek; R Rucman; S Seiwerth; V Zjacic-Rotkvic; M Duvnjak; V Jagic; E Suchanek
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

2.  The influence of dopamine agonists and antagonists on indomethacin lesions in stomach and small intestine in rats.

Authors:  P Sikirić; I Rotkvić; S Mise; S Krizanac; V Gjuris; J Jukić; E Suchanek; M Petek; I Udovicić; L Kalogjera
Journal:  Eur J Pharmacol       Date:  1988-12-06       Impact factor: 4.432

3.  Cytoprotection by prostaglandins.

Authors:  A Robert
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

4.  Effect of bromocriptine, a dopamine receptor agonist, on the experimentally induced gastric ulcers in albino rats.

Authors:  N S Parmar; M Tariq; A M Ageel
Journal:  Life Sci       Date:  1984-11-12       Impact factor: 5.037

Review 5.  Dopamine in gastrointestinal disease.

Authors:  G B Glavin; S Szabo
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

6.  Increased dopamine receptor binding in duodenal mucosa of duodenal ulcer patients.

Authors:  D E Hernandez; C H Walker; J E Valenzuela; G A Mason
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

7.  The role of dopamine in the formation of gastric ulcers in rats.

Authors:  P Sikirić; J Geber; E Suchanek; D Ivanović; V Gjuris; J Aleksić; P Reić; A Marović
Journal:  Eur J Pharmacol       Date:  1985-05-28       Impact factor: 4.432

8.  Dopamine antagonists induce gastric lesions in rats.

Authors:  P Sikirić; J Geber; D Ivanović; E Suchanek; V Gjuris; M Tućan-Foretić; S Mise; B Cvitanović; I Rotkvić
Journal:  Eur J Pharmacol       Date:  1986-11-12       Impact factor: 4.432

9.  The influence of dopamine receptor agonists and an antagonist on acute pancreatitis in rats.

Authors:  P Sikirić; I Rotkvić; S Mise; S Krizanac; V Gjuris; V Jagić; E Suchanek; M Petek; I Udovicić; J Geber
Journal:  Eur J Pharmacol       Date:  1988-03-15       Impact factor: 4.432

10.  Prolactin inhibits the development of stress-induced ulcers in the rat.

Authors:  F Drago; G Continella; G Conforto; U Scapagnini
Journal:  Life Sci       Date:  1985-01-14       Impact factor: 5.037
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.